Technical traders monitoring ilmn stock price forecast note that the 50-day moving average has crossed above the 200-day, creating a bullish crossover pattern. This momentum, combined with stronger-than-expected Q1 results, gives short-term upside potential in mid-$130s. Current share price of US$130 suggests Illumina is potentially 44% undervalued Multiple analysts have issued price targets for $ILMN recently. We have seen 12 analysts offer price targets for $ILMN in the last 6 months, with a median target of $102.5. Economic recovery in emerging markets is part of the ilmn stock price forecast outlook, with rising demand for genomic diagnostics opening fresh international revenue pipelines beyond North America.
